{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:19:17Z","timestamp":1790446757951,"version":"4.1.0"},"reference-count":47,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Dermatology"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tinea capitis presents a significant public health care challenge due to its contagious nature, and potential long\u2010term consequences if unrecognized and untreated. This review explores the prevalence, risk factors, diagnostic methods, prevention strategies, impact on quality of life, and treatment options for pediatric tinea capitis. Epidemiological analysis spanning from 1990 to 1993 and 2020 to 2023 reveals prevalence patterns of pediatric tinea capitis influenced by geographic, demographic, and environmental factors. Notably, <jats:italic>Trichophyton<\/jats:italic> species is most prevalent in North America; however, <jats:italic>Microsporum<\/jats:italic> species remain the primary causative agent globally, with regional variations. Risk factors include close contact and environmental conditions, emphasizing the importance of preventive measures. Accurate diagnosis relies on clinical evaluation, microscopic examination, and fungal culture. Various treatment modalities including systemic antifungals show efficacy, with terbinafine demonstrating superior mycological cure rates particularly for <jats:italic>Trichophyton<\/jats:italic> species. Recurrent infections and the potential development of resistance can pose challenges. Therefore, confirming the diagnosis, appropriately educating the patient\/caregiver, accurate drug and dose utilization, and compliance are important components of clinical cure. Untreated or poorly treated tinea capitis can lead to chronic infection, social stigma, and psychological distress in affected children. Prevention strategies focus on early detection and healthy lifestyle habits. Collaborative efforts between healthcare providers and public health agencies are important in treating pediatric tinea capitis and improving patient outcomes. Education and awareness initiatives play a vital role in prevention and community\u2010level intervention to minimize spread of infection. Future research should explore diagnostic advances, novel treatments, and resistance mechanisms in order to mitigate the disease burden effectively.<\/jats:p>","DOI":"10.1111\/pde.15708","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T04:59:24Z","timestamp":1723093164000},"page":"1030-1039","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["An update on tinea capitis in children"],"prefix":"10.1111","volume":"41","author":[{"given":"Aditya K.","family":"Gupta","sequence":"first","affiliation":[{"name":"Division of Dermatology, Department of Medicine University of Toronto School of Medicine  Toronto Ontario Canada"},{"name":"Research and Medical Writing Mediprobe Research Inc.  London Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruthi","family":"Polla Ravi","sequence":"additional","affiliation":[{"name":"Research and Medical Writing Mediprobe Research Inc.  London Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wang","sequence":"additional","affiliation":[{"name":"Research and Medical Writing Mediprobe Research Inc.  London Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Faour","sequence":"additional","affiliation":[{"name":"Research and Medical Writing Mediprobe Research Inc.  London Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Bamimore","sequence":"additional","affiliation":[{"name":"Research and Medical Writing Mediprobe Research Inc.  London Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candrice R.","family":"Heath","sequence":"additional","affiliation":[{"name":"Department of Urban Health and Population Science Center for Urban Bioethics, Lewis Katz School of Medicine  Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila Fallon","family":"Friedlander","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of California, San Diego School of Medicine  San Diego California USA"},{"name":"Department of Dermatology Scripps Clinic  San Diego California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/DDG.14026"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2022.02.028"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1067\/MJD.2002.120793"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.2174\/1872213X14666200106145624"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11046\u2010022\u201000702\u20100"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0280948"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.4103\/NPMJ.NPMJ_172_16"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/S11046\u2010023\u201000710\u20108"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/JDV.16951"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/MMY\/MYV057"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/jof9030366"},{"key":"e_1_2_8_13_1","first-page":"755","volume-title":"Red Book: 2021\u20132024 Report of the Committee on Infectious Diseases","author":"Committee on Infectious Diseases AA of P","year":"2021"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11046\u2010022\u201000649\u20102"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11046\u2010023\u201000732\u20102"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.31744\/EINSTEIN_JOURNAL\/2022RC6881"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13558"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/J.1439\u20100507.2012.02219.X"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.12788\/CUTIS.0630"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/BJD.13196"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/JCM13020376"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/PDE.14925"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.JAAD.2021.12.010"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/S11046\u2010016\u20100058\u20108"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20147"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/S11046\u2010023\u201000731\u20103"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.90.3.416"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1542\/PEDS.104.2.276"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/MYC.13231"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/JDV.17462"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/J.1468\u20103083.2007.02173.X"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.4103\/IJT.IJT_58_20"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11046\u2010022\u201000657\u20102"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/S11046\u2010023\u201000711\u20107"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000001034"},{"issue":"6","key":"e_1_2_8_36_1","first-page":"25","article-title":"Revealing the unseen: a review of Wood's lamp in dermatology","volume":"15","author":"Dyer J","year":"2022","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.5935\/scd1984\u20108773.201794964"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/MYC.13468"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/JOF8050546"},{"issue":"424","key":"e_1_2_8_40_1","first-page":"749","article-title":"Dermatophytes transmitted by pets and cattle","volume":"10","author":"Monod M","year":"2014","journal-title":"Rev Med Suisse"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1046\/J.1525\u20101470.1999.00050.X"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/JDV.15088"},{"key":"e_1_2_8_43_1","unstructured":"US Food and Drug Administration.GRIS\u2010PEG\u00ae (Griseofulvin ultramicrosize) tablets USP 125 MG; 250 MG Rx only (accessed May 30 2024) 2016 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/050475s057lbl.pdf."},{"key":"e_1_2_8_44_1","unstructured":"US Food and Drug Administration.DIFLUCAN\u00ae (Fluconazole tablets) (Fluconazole for oral suspension) 2019 (accessed May 30 2024) https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/019949s065 020090s047lbl.pdf."},{"key":"e_1_2_8_45_1","unstructured":"US Food and Drug Administration.LAMISIL\u00ae (Terbinafine hydrochloride) tablets for oral use 2019 (accessed May 30 2024) https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/020539s033lbl.pdf."},{"key":"e_1_2_8_46_1","unstructured":"US Food and Drug Administration.LAMISIL\u00ae (terbinafine hydrochloride) oral granules 125\u2009mg and 187.5\u2009mg. For oral use 2013 (accessed May 30 2024) https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/022071s009lbl.pdf."},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1001\/JAMADERMATOL.2017.4483"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.JAAD.2021.01.073"}],"container-title":["Pediatric Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pde.15708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T08:54:51Z","timestamp":1732092891000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pde.15708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1111\/pde.15708"],"URL":"https:\/\/doi.org\/10.1111\/pde.15708","archive":["Portico"],"relation":{},"ISSN":["0736-8046","1525-1470"],"issn-type":[{"value":"0736-8046","type":"print"},{"value":"1525-1470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]},"assertion":[{"value":"2024-04-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}